Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors.

Authors:
Ennes-Vidal V; Dos Santos ALS; Branquinha MH; d'Avila-Levy CM.

Journal:
Mem Inst Oswaldo Cruz

Publication Year: 2022

DOI:
10.1590/0074-02760220017

PMCID:
PMC8958894

PMID:
35352772

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mem Inst Oswaldo Cruz

Abbreviation: Mem Inst Oswaldo Cruz

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Tropical Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients…
de Carvalho JC; Pascoal-Xavier MA; Araújo MG and 5 more (2024) - Transparency Score: 2/6
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
Pinto MA; da Silva ADS; Rodrigues DDRF and 5 more (2023) - Transparency Score: 2/6
An increased number of individuals of a potential host facilitates non-photic synchronisation in th…
Valentinuzzi/ VS; Abrahan LB. (2023) - Transparency Score: 2/6
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be…
Lannes-Vieira J; Vilar-Pereira G; Barrios LC and 1 more (2023) - Transparency Score: 2/6
A review of serological tests available in Brazil for intestinal schistosomiasis diagnosis.
Ramos LMDS; da Silva-Pereira RA; Oliveira E and 2 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"VEV, MHB, ALSS, RFSMB and CML - Conceived and designed the main idea; VEV, MHB, ALSS and CML wrote the paper. All authors read and approved the final manuscript. The authors declare that they have no conflict of interest."

Evidence found in paper:

"Financial support: CNPq, FAPERJ, CAPES (Financial code - 001), FIOCRUZ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025